Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

AADAC anticorps (AA 201-300)

L’anticorps Souris Monoclonal anti-AADAC a été validé pour WB et ELISA. Il convient pour détecter AADAC dans des échantillons de Humain. Il y a 5+ publications disponibles.
N° du produit ABIN513029

Aperçu rapide pour AADAC anticorps (AA 201-300) (ABIN513029)

Antigène

Voir toutes AADAC Anticorps
AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Reactivité

  • 24
  • 17
  • 16
  • 4
  • 2
  • 2
  • 2
  • 1
Humain

Hôte

  • 38
  • 1
Souris

Clonalité

  • 39
Monoclonal

Conjugué

  • 15
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp AADAC est non-conjugé

Application

  • 28
  • 13
  • 13
  • 11
  • 5
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA

Clone

2E8
  • Épitope

    • 15
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 201-300

    Fonction

    Mouse monoclonal antibody raised against a partial recombinant AADAC.

    Séquence

    QLLDDPDVKI KLKIQSLIYP ALQPLDVDLP SYQENSNFLF LSKSLMVRFW SEYFTTDRSL EKAMLSRQHV PVESSHLFKF INWSSLLPER FIKGHVYNNP

     Réactivité croisée

    Humain

    Attributs du produit

    Antibody Reactive Against Recombinant Protein.

    Immunogène

    AADAC (NP_001077, 201 a.a. ~ 300 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

    Isotype

    IgG2b
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Buffer

    In 1x PBS, pH 7.4

    Conseil sur la manipulation

    Aliquot to avoid repeated freezing and thawing.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Muta, Fukami, Nakajima, Yokoi: "N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity." dans: Biochemical pharmacology, Vol. 87, Issue 2, pp. 352-9, (2014) (PubMed).

    Kobayashi, Fukami, Nakajima, Watanabe, Nakajima, Yokoi: "Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse." dans: Drug metabolism and disposition: the biological fate of chemicals, Vol. 40, Issue 4, pp. 671-9, (2012) (PubMed).

    Shimizu, Fukami, Kobayashi, Takamiya, Aoki, Nakajima, Yokoi: "A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity." dans: Drug metabolism and disposition: the biological fate of chemicals, Vol. 40, Issue 6, pp. 1183-90, (2012) (PubMed).

    Kobayashi, Fukami, Higuchi, Nakajima, Yokoi: "Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia." dans: Biochemical pharmacology, Vol. 84, Issue 9, pp. 1196-206, (2012) (PubMed).

    Watanabe, Fukami, Nakajima, Takamiya, Aoki, Yokoi: "Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis." dans: Drug metabolism and disposition: the biological fate of chemicals, Vol. 37, Issue 7, pp. 1513-20, (2009) (PubMed).

  • Antigène

    AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

    Autre désignation

    AADAC

    Sujet

    Full Gene Name: arylacetamide deacetylase (esterase)
    Synonyms: CES5A1,DAC

    ID gène

    13

    NCBI Accession

    NM_001086
Vous êtes ici:
Chat with us!